NuvaRing Mega Study





Treatment Effectiveness

User reported effectiveness ratings NuvaRing for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Endometriosis 5% 20% 25% 25% 25% 40
Polycystic Ovary Syndrome (PCOS) 0% 75% 0% 25% 0% 4
Vulvodynia 0% 10% 37% 40% 13% 30

Side Effects

User-reported side effects of NuvaRing

Side Effect Percent of Reports NuvaRing
Nervousness 6%
Acne 25%
Breasts That Are Large, Tender, or Produce a Liquid 25%
Changes in Appetite 38%
Growth of Hair on Face 7%
Loss of Hair on Scalp 6%
Runny Nose 13%
Seizures 6%
Stomach Cramps or Bloating 25%
Swelling, Redness, Irritation, Burning, Itching, or Infection of the Vagina 25%
Vaginal Bleeding or Spotting When It Is Not Time for Your Period. (Call Your Doctor if the Bleeding 41%
Vomiting 6%
Weight Gain or Loss 25%
White or Yellow Vaginal Discharge 31%
Headache 44%
Nausea 38%
Changes in Sexual Desire 33%

Below is the degree of change seen after NuvaRing is higher than average.

Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
Change in the listed outcome after is higher than average.

NuvaRing Info

Property Value
Variable Name NuvaRing
Aggregation Method SUM
Analysis Performed At 2020-04-07
Duration of Action 21 days
Filling Value 0
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 0
Number of Measurements (including those generated by tagged, joined, or child variables) 0
Public true
Onset Delay 30 minutes
Unit Count
User Variables 0
Variable Category Treatments
Variable ID 94649